UC8-12185-33300 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Dose 1 — Pfizer-BioNTech
2021-01-08
Registered in v-safe
2021-01-08
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-10
Dose 2 — Pfizer-BioNTech
2021-01-12
Survey response — days 1–6 daily, dose 2
MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches · Be unable to work

Free text: Sweats

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2022-01-10
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-10	Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Sweats

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Hyperhidrosis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release